BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19405133)

  • 41. Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer.
    Higgins K; Chino JP; Marks LB; Ready N; D'Amico TA; Clough RW; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1462-7. PubMed ID: 19467798
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment results of the Ewing sarcoma of bone and prognostic factors.
    Sari N; Toğral G; Cetindağ MF; Güngör BS; Ilhan IE
    Pediatr Blood Cancer; 2010 Jan; 54(1):19-24. PubMed ID: 19760772
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and cytogenetic features of a population-based consecutive series of 285 pediatric T-cell acute lymphoblastic leukemias: rare T-cell receptor gene rearrangements are associated with poor outcome.
    Karrman K; Forestier E; Heyman M; Andersen MK; Autio K; Blennow E; Borgström G; Ehrencrona H; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kerndrup G; Nordgren A; Palmqvist L; Johansson B; ; ;
    Genes Chromosomes Cancer; 2009 Sep; 48(9):795-805. PubMed ID: 19530250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of socioeconomic status on childhood acute lymphoblastic leukemia treatment in Indonesia.
    Mostert S; Sitaresmi MN; Gundy CM; Sutaryo ; Veerman AJ
    Pediatrics; 2006 Dec; 118(6):e1600-6. PubMed ID: 17074838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperglycemia during induction therapy is associated with increased infectious complications in childhood acute lymphocytic leukemia.
    Sonabend RY; McKay SV; Okcu MF; Yan J; Haymond MW; Margolin JF
    Pediatr Blood Cancer; 2008 Sep; 51(3):387-92. PubMed ID: 18523991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retrospective analysis of the impact of symptom duration on prognosis in soft tissue sarcoma.
    Saithna A; Pynsent PB; Grimer RJ
    Int Orthop; 2008 Jun; 32(3):381-4. PubMed ID: 17377790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.
    Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA
    Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome.
    Woo DK; Jones CR; Vanoli-Storz MN; Kohler S; Reddy S; Advani R; Hoppe RT; Kim YH
    Arch Dermatol; 2009 Jun; 145(6):667-74. PubMed ID: 19528422
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
    Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
    Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer.
    Athale U; Siciliano S; Thabane L; Pai N; Cox S; Lathia A; Khan A; Armstrong A; Chan AK
    Pediatr Blood Cancer; 2008 Dec; 51(6):792-7. PubMed ID: 18798556
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extreme drug resistance assay results do not influence survival in women with epithelial ovarian cancer.
    Karam AK; Chiang JW; Fung E; Nossov V; Karlan BY
    Gynecol Oncol; 2009 Aug; 114(2):246-52. PubMed ID: 19500821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute leukemia in patients sixty years of age and older: a twenty year single institution review.
    Leger CS; Leitch HA; Galbraith PF; Li CH; Vickars LM
    Am J Clin Oncol; 2009 Apr; 32(2):137-41. PubMed ID: 19307947
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group.
    Tsukimoto I; Tawa A; Horibe K; Tabuchi K; Kigasawa H; Tsuchida M; Yabe H; Nakayama H; Kudo K; Kobayashi R; Hamamoto K; Imaizumi M; Morimoto A; Tsuchiya S; Hanada R
    J Clin Oncol; 2009 Aug; 27(24):4007-13. PubMed ID: 19620491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treating Pediatric soft tissue sarcomas in a country with limited resources: the experience of the Unidad Nacional de Oncologia Pediatrica in Guatemala.
    Antillon F; Castellanos M; Valverde P; Luna-Fineman S; Garrido C; Serrato T; Rodriguez-Galindo C; Casanova M; Ferrari A
    Pediatr Blood Cancer; 2008 Dec; 51(6):760-4. PubMed ID: 18680154
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trends in survival after childhood cancer in Slovenia between 1957 and 2007.
    Perme MP; Jereb B
    Pediatr Hematol Oncol; 2009 Jun; 26(4):240-51. PubMed ID: 19437326
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical Predictors and Prognostic Model for Pediatric Lymphoblastic Lymphoma Treated With Uniform BFM90 Protocol: A Single-Center Experience of 65 Patients From Asia.
    Patel A; Tiwari A; Biswas B; Chand Sharma M; Vishnubhatla S; Bakhshi S
    Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e291-e298. PubMed ID: 30905539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Convulsive status epilepticus: clinical profile in a developing country.
    Murthy JM; Jayalaxmi SS; Kanikannan MA
    Epilepsia; 2007 Dec; 48(12):2217-23. PubMed ID: 17651412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic factors of treatment outcomes in patients with granulocytic sarcoma.
    Lan TY; Lin DT; Tien HF; Yang RS; Chen CY; Wu K
    Acta Haematol; 2009; 122(4):238-46. PubMed ID: 19887783
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with Down syndrome.
    Shah N; Al-Ahmari A; Al-Yamani A; Dupuis L; Stephens D; Hitzler J
    Pediatr Blood Cancer; 2009 Jan; 52(1):14-9. PubMed ID: 18802938
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experience.
    Ulrickson M; Aldridge J; Kim HT; Hochberg EP; Hammerman P; Dube C; Attar E; Ballen KK; Dey BR; McAfee SL; Spitzer TR; Chen YB
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1447-54. PubMed ID: 19822305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.